POSTER SESSION III
Tuesday, March 20, 2012   —  9:30 AM - 12:00 Noon
CC Exhibit Hall B3 & C


Click on the blue numbers in parentheses to display abstracts.
Click the button next to any title to add to Itinerary Planner...


PAN-GENOMIC/PAN-PROTEOMIC APPROACHES TO DISEASES



Poster#Title and AuthorsItinerary
Planner
266 Genomic Landscape of Bladder Cancer Development from Incipient Field Effects to Invasive Disease (1894)
T Majewski, J Bondaruk, S Zhang, S Lee, K Baggerly, C Dinney, HB Grossman, XF Wu, J-P Issa, W Zhang, R Gibbs, SE Scherer, BA Czerniak - UT MD Anderson Cancer Center, Houston, TX; Fels Institute for Cancer Research and Molecular Biology, Philadelphia, PA; Baylor College of Medicine, Houston, TX 		Add
267 A Novel microRNA-Based Test Demonstrate above 90% Accuracy in Classification of Metastatic Tumors from Patients Diagnosed with Carcinoma of Unknown Primary (1901)
M Sanden, G Pentheroudakis, B St. Cyr, A Goussia, D Lebanony, K Stoyianni, A Faerman, G Fountzilas, L Cohen, V Malamou-Mitsi, N Pavlidis - Rosetta Genomics Inc., Philadelphia, PA; Ioannina University Hospital, Ioannina, Greece; Rosetta Genomics Ltd., Rehovot, Israel; Hellenic Cooperative Oncology Group, Athens, Greece 		Add
268 Renal Cell Tumors Share Common Type-Specific Copy Number Variations Identified Via SNP Arrays and Whole Genome Sequencing (1889)
WA LaFramboise, SI Bastacky, AV Parwani, R Dhir - University of Pittsburgh, Pittsburgh, PA 		Add
269 Backward Chaining Rule Induction Using Multiple Genomic Data Types To Understand Gene Interactions in Ovarian Cancer (1883)
SC Chekuri, ME Edgerton - UT MD Anderson Cancer Center, Houston, TX 		Add
270 ProtAnalyzer: A Customizable Software for Prediction of Kinase Targets in the Complete Proteome (1896)
C Montemayor, E Villegas, J Rosen - University of Wisconsin Hospital and Clinics, Madison, WI; Baylor College of Medicine, Houston, TX 		Add
271 A Target Capture Based Next Generation Sequencing Panel for Identification of Reurrent Somatic Mutations in Cancer (1885)
E Duncavage, D Spencer, H Abel, S Kulkarni, K Seibert, R Nagarajan, R Mitra, M Watson, J Pfeifer - Washington University, St. Louis, MO; Washington University, St Louis, MO 		Add
272 Identification of Microvascular Invasion Biomarkers in Hepatocellular Carcinomas by MALDI Imaging Mass Spectrometry (1899)
N Pote, T Alexandrov, S Laouirem, J Belghiti, P Bedossa, V Paradis - Beaujon Hospital, Assistance Publique-Hôpitaux de Paris, Clichy, France; INSERM U773, Beaujon Hospital, Clichy, France; University of Bremen, Bremen, Germany; University Denis Diderot, Paris, France 		Add
273 Identification of Heterogeneous Nuclear Ribonucleoprotein K (hnRNP K) as a Biomarker in Hepatocellular Carcinoma in Patients with Cirrhosis by Proteomic and Immunohistochemical Studies (1886)
Y Guo, J Zhao, J Bi, M Chen - Beijing Jishuitan Hospital, Beijing University Health Science Center, Beijing, China; University of California Davis Medical Center, Sacramento, CA 		Add
274 Multisite Analytical Validation of a 92-Gene Molecular Classifier for Cancers of Uncertain Primary (1888)
SE Kerr, CA Schnabel, PS Sullivan, Y Zhang, V Singh, B Carey, MG Erlander, WE Highsmith, SM Dry, EF Brachtel - Mayo Clinic, Rochester, MN; bioTheranostics, Inc., San Diego, CA; University of California Los Angeles, Los Angeles, CA; Massachusetts General Hospital, Boston, MA 		Add
275 Piwi-Interacting RNAs Are Differentially Expressed in Renal Cell Carcinoma and Its Metastasis (1893)
Y Li, X Wu, H Gao, X Li, JM Jin, F Wang, B Mu, J Wang, YS Kim, LM Weiss, H Wu - City of Hope National Medical Center and Beckman Research Institute, Duarte, CA; Third Military Medical University, Chongqing, China 		Add
276 Identification of Circulating Autoantibodies as Novel Ovarian Cancer Biomarkers (1897)
MA Murphy, DJ OŽConnell, JK OŽBrien, S OŽToole, SL OŽKane, C Martin, O Sheils, JJ OŽLeary, DJ Cahill - Trinity College Dublin, Dublin, Ireland; University College Dublin, Dublin, Ireland 		Add
277 Rr-1, a Novel Ribosomal RNA-Derived Small Non-Coding RNA, Is Involved in Renal Cell Carcinoma Metastasis (1892)
Y Li, X Wu, H Gao, C Guo, JM Jin, F Wang, B Mu, X Li, J Wang, M DŽApuzzo, LM Weiss, H Wu - City of Hope National Medical Center and Beckman Research Institute, Duarte, CA; Third Military Medical University, Chongqing, China 		Add
278 CpG Island-Containing BRCA1 Distal Promoter Is Associated with Breast Stem Cells and Resistance to Doxorubicin (1903)
R Shen, W Zhou, Z Peng, M Teng, Y Liu, A Toland, K-Y Teng, JR Chao, S Liu, M Wicha, H-JL Lin - The Ohio State University, Columbus, OH; Indiana University, Indianapolis, IN; University of Arizona, Phoenix, AZ 		Add
279 Prolonged Room Temperature Ischemia Does Not Affect the Quality of Total Tissue RNA (1908)
L True, B Nghiem, B Lakely, C Morrissey - University of Washington, Seattle 		Add
280 Assessment of CGH-Array Usefulness in Metachronous Tumors (1891)
F Le Loarer, P Lagarde, A Neuville, JM Coindre, F Chibon - Rouen University Hospital, Rouen, France; Institut Bergonié, Bordeaux, France 		Add
281 Stemness Gene Expression Profiles in Cancer Stem Cell Progenies Derived from a Cell Line Panel +/- BRAF Mutation (1904)
G Sommerville, P Smyth, JJ OŽLeary, O Sheils - Trinity College Dublin, Dublin, Ireland 		Add
282 Whole Exome Sequencing of Both Components of a Mixed Adenocarcinoma/Small Cell Carcinoma of the Gallbladder (1911)
LD Wood, Y Jiao, A Maitra, P Argani, JL Cameron, N Papadopoulos, KW Kinzler, B Vogelstein, RH Hruban - Johns Hopkins University School of Medicine, Baltimore, MD 		Add
283 Functional Correlates of Jab1 Networks in Triple Negative Breast Cancer (1902)
MM Sasamoto, TT Vu, FX Claret, ME Edgerton - UT MD Anderson Cancer Center, Houston, TX 		Add
284 Diagnostic Value of DNA Mutational Analysis of Residual Liquid Gynecologic Cytology in Detecting Malignancy (1898)
S Patel, AR Smith, A Mohanty, U Krishnamurti, C Binkert, B Ujevich, SJ Bokhari, JF Silverman, SD Finklestein, Y Liu - Allegheny General Hospital, Pittsburgh, PA; RedPath Integrated Pathology, Inc., Pittsburgh, PA 		Add
285 Global 5-Hydroxymethylcytosine Content Is Significantly Reduced in Human Cancers (1887)
MC Haffner, A Chaux, AK Meeker, DM Esopi, J Gerber, LG Pellakuru, A Toubaji, P Argani, C Iacobuzio-Donahue, WG Nelson, GJ Netto, AM De Marzo, S Yegnasubramanian - Johns Hopkins University, Baltimore, MD 		Add
286 Molecular and Clinicopathologic Characteristics of HER2 Mutant Lung Adenocarcinoma (ADC) (1900)
S Roy Chowdhuri, J Chaft, K Nafa, M Kris, M Zakowski, M Ladanyi, M Arcila - Memorial Sloan-Kettering Cancer Center, New York 		Add
287 Salinomycin: Antitumoral Effects and Gene Expression in Neuroblastoma Cells (1910)
P Weerasinghe, ML Buja, RE Brown - UT Health Medical School, Houston, TX 		Add
288 Absence of ERG Expression Predicts Early Prostate Cancer Biochemical Recurrence When Combined with DNA Methylation Status of a Development-Associated Gene (1907)
D Trudel, K Kron, L Liu, J Trachtenberg, N Fleshner, B Bapat, TH Van der Kwast - Princess Margaret Hospital, University Health Network, Toronto, Canada; Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, Canada 		Add
289 Downregulation of Genes Contributes to Chemoresistance Induced by Hypoxia (1895)
LM McEvoy, SA OŽToole, CD Spillane, CM Martin, O Sheils, JJ OŽLeary - Trinity College Dublin, Dublin, Ireland 		Add
290 MiR-335 Is Upregulated upon Retinoic Acid-Induced Differentiation of NTera-2 Human Embryonal Carcinoma Cell Line and Can Induce Differentiation (1909)
S Vencken, M Gallagher, S Elbaruni, C Martin, O Sheils, J OŽLeary - Trinity College Dublin, Dublin, Ireland 		Add
291 Mass Spectrometry-Based Glycoproteomic Profiling Identifies SIRP alpa as a Potential Protein Biomarker in Primary Mediastinal Large B-Cell Lymphoma (1882)
NA Brown, D Rolland, D Fermin, V Basrur, D Thomas, F Keyoumarsi, K Conlon, KSJ Elenitoba-Johnson, MS Lim - University of Michigan, Ann Arbor, MI 		Add